# A Study of LY2623091 in Male and Females With Chronic Kidney Disease

> **NCT01427972** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 42 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** LY2623091
- **DRUG:** Eplerenone

## Key facts

- **NCT ID:** NCT01427972
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01427972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01427972, "A Study of LY2623091 in Male and Females With Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01427972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*